| PACKAGING TYPE: | 10x1x15 Bister (10 Monocarton In 1 Box) |
| COMPOSITION: | Each Uncoated Bilayered Tablet Contains: Myo-inositol Bp 600mg, Metformin Hydrochloride (in Sustained Release Form) Ip 500mg, Excipients Q.s. Colour: Sunset yellow fcf |
| FORMULATION: | Tablet |
| Description: | METFIG-M 500/600 Tablet is a combination medication used to support blood sugar control and improve insulin sensitivity. It contains Metformin Hydrochloride (Sustained Release) 500 mg and **Myo‑Inositol 600 mg. Metformin helps reduce glucose production in the liver and improves the body’s response to insulin, thereby lowering blood sugar levels. Myo-inositol plays an important role in cellular signaling and helps improve insulin sensitivity and metabolic balance. This combination is commonly used in the management of Type 2 Diabetes Mellitus and may also support metabolic health in conditions such as Polycystic Ovary Syndrome (PCOS) where insulin resistance is a key factor. |
| Side Effects: | Some individuals may experience mild side effects, such as: Nausea or stomach upset Diarrhea Loss of appetite Metallic taste in the mouth Abdominal discomfort If severe or persistent symptoms occur, consult a healthcare professional. |
| How to Use: | Take METFIG-M 500/600 Tablet as directed by a healthcare professional. Swallow the tablet whole with water after meals. Do not crush or chew sustained-release tablets. Follow a healthy diet and exercise routine along with medication. |
| Precaution: | Use cautiously in patients with kidney or liver disorders. Avoid excessive alcohol consumption while taking this medication. Regular monitoring of blood glucose levels is recommended. Inform your doctor about other medications you are taking. Pregnant or breastfeeding women should consult a doctor before use. Store in a cool, dry place away from direct sunlight. |
| Product Benefits: | Helps control blood glucose levels. Improves insulin sensitivity. Supports metabolic health in Type 2 Diabetes. Useful in managing insulin resistance associated with PCOS. Sustained-release formulation ensures prolonged therapeutic effect. |
Frequently Asked Questions
It is used to control blood sugar levels and improve insulin sensitivity in patients with Type 2 Diabetes and insulin resistance.
Myo-inositol improves insulin signaling and metabolic function, helping regulate blood glucose and hormonal balance.
Yes, doctors may prescribe it to help manage insulin resistance associated with PCOS.










